Moreover, exclusive expression of the folate receptor-2 (FR-2) in the activated macrophages present at sites of chronic inflammation, including in rheumatoid arthritis (RA), osteoarthritis (OA), atherosclerosis, and inflammatory bowel disease (IBD) makes it an excellent candidate for targeted delivery to macrophages. The gene discussed is FOLR2; the disease is rheumatoid arthritis.